Roche has decided to stop developing satralizumab for bone health in Duchenne muscular dystrophy, the company announced.

After following the Olympics, columnist Robin Stemple envisions a future with new treatments and even a cure for FSHD.

Dosing has begun in a Phase 2 clinical trial testing the experimental oral therapy SAT-3247 in boys with Duchenne muscular ...

Researchers identified a molecular pathway that can limit muscle repair, a finding that may guide future muscular dystrophy treatments.

After years of focusing on her large family, and three sons with Duchenne MD, columnist Betty Vertin is eager to reconnect with friends.

Columnist Shalom Lim has discovered that a personal sense of belonging is built through simple presence. Art can help foster ...

Lasting gains in swallowing ability have been reported for four people with oculopharyngeal muscular dystrophy given gene therapy in a trial.

Columnist Patrick Moeschen turns to classic writers and poets to express how he is choosing hope in life with limb-girdle muscular dystrophy.

A clinical trial testing Duchenne gene-editing therapy candidate PBGENE-DMD will soon launch in the U.S., having won clearance from the FDA.

Guest writer Matthew Busch says that, despite the setbacks and surgeries he's endured, he's now thriving in life with Duchenne MD.

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Dyscorban (ifetroban), Cumberland Pharmaceuticals’ treatment candidate for heart problems in Duchenne muscular ...